BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
66.09
+0.08 (0.12%)
Nov 5, 2024, 1:19 PM EST - Market open
BioMarin Pharmaceutical Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 5, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 12,596 | 18,162 | 19,234 | 16,220 | 15,918 | 15,187 | |
Market Cap Growth | -19.63% | -5.57% | 18.58% | 1.90% | 4.81% | 0.17% | |
Enterprise Value | 12,253 | 18,132 | 19,051 | 16,229 | 15,917 | 15,375 | |
Last Close Price | 66.01 | 96.42 | 103.49 | 88.35 | 87.69 | 84.55 | |
PE Ratio | 39.27 | 110.83 | 137.99 | -252.11 | 19.49 | -634.76 | |
PS Ratio | 4.54 | 7.51 | 9.18 | 8.79 | 8.56 | 8.91 | |
PB Ratio | 2.32 | 3.67 | 4.18 | 3.80 | 3.88 | 4.86 | |
P/FCF Ratio | 39.33 | 290.28 | 350.06 | 77.63 | -549.91 | -156.95 | |
P/OCF Ratio | 30.34 | 114.04 | 109.34 | 53.26 | 186.47 | 314.68 | |
EV/Sales Ratio | 4.45 | 7.49 | 9.09 | 8.79 | 8.56 | 9.02 | |
EV/EBITDA Ratio | 28.76 | 65.58 | 111.45 | 481.22 | 1186.81 | 34707.47 | |
EV/EBIT Ratio | 37.54 | 105.36 | 276.25 | -218.38 | -173.47 | -146.63 | |
EV/FCF Ratio | 38.30 | 289.80 | 346.74 | 77.67 | -549.88 | -158.90 | |
Debt / Equity Ratio | 0.11 | 0.23 | 0.24 | 0.26 | 0.28 | 0.29 | |
Debt / EBITDA Ratio | 1.37 | 3.90 | 6.07 | 23.56 | 43.10 | 67.53 | |
Debt / FCF Ratio | 1.88 | 18.12 | 20.38 | 5.38 | -39.08 | -9.40 | |
Asset Turnover | 0.40 | 0.37 | 0.34 | 0.31 | 0.35 | 0.37 | |
Inventory Turnover | 1.19 | 1.26 | 1.36 | 1.49 | 1.67 | 1.77 | |
Quick Ratio | 2.39 | 1.45 | 2.98 | 2.54 | 3.07 | 1.21 | |
Current Ratio | 4.27 | 2.51 | 4.67 | 4.16 | 4.76 | 2.08 | |
Return on Equity (ROE) | 6.25% | 3.51% | 3.19% | -1.53% | 23.63% | -0.78% | |
Return on Assets (ROA) | 3.00% | 1.63% | 0.70% | -0.78% | -1.09% | -1.44% | |
Return on Capital (ROIC) | 3.40% | 1.82% | 0.78% | -0.87% | -1.24% | -1.67% | |
Earnings Yield | 2.56% | 0.92% | 0.74% | -0.40% | 5.37% | -0.16% | |
FCF Yield | 2.54% | 0.34% | 0.29% | 1.29% | -0.18% | -0.64% | |
Buyback Yield / Dilution | -0.93% | -1.39% | -3.34% | 4.60% | -7.06% | -1.00% | |
Total Shareholder Return | -0.93% | -1.39% | -3.34% | 4.60% | -7.06% | -1.00% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.